BUY Cipla Ltd. — Somil Mehta, Sharekhan
bySomil Mehta, SharekhanHorizon: NA (inferred Swing (≤2wk))24 Sept 2026via CNBC Awaaz.
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
3 advisors have active short-term BUY calls on this stock, with 1 issued in the last 14 days
Advisor consensus · adjacent horizon·21 Sept · 6d ago
Wockhardt Share Price Today: 2.19% rise and sector view
NewsGoogle News·17 Sept · 1w ago
ICICI Lombard, United Breweries And Cipla: Three Stocks That Bucked The Trend As Stock Market Crashed
NewsNdtv-Profit·24 Sept · 3d ago
Anthem Biosciences Share Price Today: valuation and peers
NewsGoogle News·18 Sept · 1w ago
SYMBIOTEC Share Price News: price rise and valuation view
NewsGoogle News·18 Sept · 1w ago
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Cipla
- BUY — Arun Kumar Mantri13 Nov 2026 · Same day · target ₹1,450 · Expired
- BUY — Rajesh Satpute8 Nov 2026 · Next day · target ₹1,440 · Expired
- BUY — Prakash Gaba4 Nov 2026 · Same day · target ₹1,410 · Expired
- BUY — Kush Bohra3 Nov 2026 · Same day · target ₹1,415 · Expired
- BUY — Rakesh Bansal2 Nov 2026 · Same day · target ₹1,407 · Expired
More from Somil Mehta, Sharekhan
- BUY GE Vernova T&D India13 Nov 2026 · ~2 weeks · target ₹4,790 · Active
- BUY Eicher Motors13 Nov 2026 · ~2 weeks · target ₹8,000 · Active
- BUY TBO Tek12 Nov 2026 · ~2 weeks · target ₹1,750 · Active
- BUY Max Healthcare Institute12 Nov 2026 · ~2 weeks · target ₹1,000 · Active
- BUY Kalyan Jewellers India12 Nov 2026 · ~2 weeks · target ₹800 · Active

